MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML)

NCT03412292 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Maxinovel Pty., Ltd.